New Weight-Loss drug put to the test in paraguay
NCT ID NCT07492563
Summary
This study will follow 300 adults with obesity in Paraguay for one year to see how safe and effective the medication tirzepatide is in real-world use. Participants will receive weekly injections to help with weight loss and improve related health measures like blood sugar and cholesterol. The main goal is to monitor for side effects while also tracking how much weight people lose and how their overall health changes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Endocrinology Unit, UNA, Py
Asunción, Paraguay
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.